EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-based multi-pocket virtual screening identifies FDA-approved candidate compounds targeting MPXV thymidylate kinase

Hanwen Lu, Xiaodong Li, Zhanxiang Wang

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1743154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Hanwen Lu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Labora…. Hauptthemen laut MEDLINE: Antiviral Agents, Nucleoside-Phosphate Kinase, Monkeypox virus. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mpox, caused by monkeypox virus (MPXV), has emerged as a growing global health concern, yet effective targeted antiviral therapies remain limited. Thymidylate kinase (TMK), an essential enzyme required for viral DNA replication, represents a potential therapeutic target.

Methods

We established a structure-based drug repurposing workflow integrating multi-pocket virtual screening and molecular dynamics (MD) simulations. A curated library of FDA-approved compounds was screened across five predicted TMK binding pockets, followed by consensus ranking based on cross-pocket recurrence and docking scores. Top candidates were further evaluated using multiple independent MD simulations to assess binding stability and conformational dynamics.

Results

Phylogenetic and structural analyses indicated that MPXV TMK is highly conserved among orthopoxviruses while structurally distinct from the human homolog. Virtual screening identified several prioritized candidates, among which capmatinib (DB11791), nebivolol (DB04861), and tucatinib (DB11652) consistently ranked highly across multiple pockets. MD simulations showed that all systems approached relatively stable conformational regimes after the initial phase of the simulations. Notably, DB11791 exhibited lower ligand RMSD and more stable pocket retention across independent simulations. Free energy landscape analysis further suggested that DB11791 adopted a more confined low-energy conformational state compared to other candidates.

Conclusion

These findings suggest that DB11791 may represent a promising TMK-targeting candidate. More broadly, the combined multi-pocket consensus screening and dynamic evaluation strategy provides a computational framework for antiviral drug repurposing. Further experimental validation is required to confirm the antiviral activity of these candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsNucleoside-Phosphate KinaseMonkeypox virusMolecular Dynamics SimulationHumansDrug RepositioningMolecular Docking SimulationBinding SitesDrug Evaluation, PreclinicalMpox, MonkeypoxUnited States

Stichwörter der Autor:innen

drug repurposingmolecular dynamicsmonkeypox virusthymidylate kinasevirtual screening

Substanzen

dTMP kinaseAntiviral AgentsNucleoside-Phosphate Kinase

Autor:innen und Institutionen

  • Department of Neurosurgery and Department of Neuroscience, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, Xiamen Key Laboratory of Brain Center, the First Affiliated Hospital of Xiamen Universi…
  • College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Institute of Clinical Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.
  • Xiamen Key Laboratory of Brain Center, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.

Zitieren

APA

Lu, H., Li, X., & Wang, Z. (2026). Structure-based multi-pocket virtual screening identifies FDA-approved candidate compounds targeting MPXV thymidylate kinase. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1743154

Vancouver

Lu H, Li X, Wang Z. Structure-based multi-pocket virtual screening identifies FDA-approved candidate compounds targeting MPXV thymidylate kinase. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1743154

BibTeX
@article{Lu2026,
  author = {Lu, Hanwen and Li, Xiaodong and Wang, Zhanxiang},
  title = {Structure-based multi-pocket virtual screening identifies FDA-approved candidate compounds targeting MPXV thymidylate kinase},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1743154}
}
Kostenlos starten →